Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sopharma's sales up by 6% last year

This article was originally published in Scrip

Executive Summary

Unconsolidated sales of Sopharma, the second-largest pharmaceutical company in Bulgaria, increased by almost 6% to Lev169.9 million ($113.4 million) last year. Its net profit was affected by growing labour and raw material costs and fell by 30% to Lev19.2 million.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC001816

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel